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Congenital myasthenic syndromes (CMS) result from reduced cholinergic transmission at neuromuscular junctions (NMJs). While the etiology of CMS varies, the disease is characterized by muscle weakness. To date, it
remains unknown if CMS causes long-term and irreversible changes to skeletal muscles. In this study, we examined skeletal muscles in a mouse line with reduced expression of Vesicular Acetylcholine Transporter (VAChT,
mouse line herein called VAChT-KDHOM). We examined this mouse line for several reasons. First, VAChT plays a
central function in loading acetylcholine (ACh) into synaptic vesicles and releasing it at NMJs, in addition to
other cholinergic nerve endings. Second, loss of function mutations in VAChT causes myasthenia in humans.
Importantly, VAChT-KDHOM present with reduced ACh and muscle weakness, resembling CMS. We evaluated the
morphology, ﬁber type (myosin heavy chain isoforms), and expression of muscle-related genes in the extensor
digitorum longus (EDL) and soleus muscles. This analysis revealed that while muscle ﬁbers atrophy in the EDL,
they hypertrophy in the soleus muscle of VAChT-KDHOM mice. Along with these cellular changes, skeletal
muscles exhibit altered levels of markers for myogenesis (Pax-7, Myogenin, and MyoD), oxidative metabolism
(PGC1-α and MTND1), and protein degradation (Atrogin1 and MuRF1) in VAChT-KDHOM mice. Importantly, we
demonstrate that deleterious changes in skeletal muscles and motor deﬁcits can be partially reversed following
the administration of the cholinesterase inhibitor, pyridostigmine in VAChT-KDHOM mice. These ﬁndings reveal
that fast and slow type muscles diﬀerentially respond to cholinergic deﬁcits. Additionally, this study shows that
the adverse eﬀects of cholinergic transmission, as in the case of CMS, on fast and slow type skeletal muscles are
reversible.

1. Introduction
Congenital Myasthenic Syndromes (CMS) are a group of genetic
disorders that impair neuromuscular transmission, resulting in muscle

weakness (Aran et al., 2017; O'Neill, 2006). CMS are generally caused
by mutations in presynaptic and postsynaptic genes with crucial roles in
cholinergic transmission at the neuromuscular junction (NMJ) (Ohno
et al., 2017). One of the most relevant proteins for cholinergic
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Abbreviations
ACh
ALS
ChAT
CMS
CSA
EDL
MIT
MTND1
MuRF1
MyHC
MyoD

AChRs
NMJ
Pax-7
PGC1-α

nicotinic receptors
neuromuscular junctions
paired box protein 7
peroxisome proliferator-activated receptor gamma coactivator 1-alpha
PYR
pyridostigmine
SLC18A3 solute carrier family 18 member A3
SMA
spinal muscular atrophy
SR
sarcoplasmic reticulum
TEM
transmission electron microscopy
TTX
tetrodotoxin
VAChT KDHOM VAChT knockdown Homozygous mice
VAChT vesicular acetylcholine transporter

acetylcholine
amyotrophic lateral sclerosis
choline acetyltransferase
congenital myasthenic syndrome
cross sectional area
extensor digitorum longus muscle
maximal incremental test
mitochondrial DNA encoding complex 1
muscle RING-ﬁnger protein-1
myosin heavy chain
myogenic diﬀerentiation 1

Chakkalakal et al., 2010; Schiaﬃno et al., 1989; Schiaﬃno and
Reggiani, 2011). These muscle ﬁbers also show diﬀerent responses to
various diseases and aging. Despite this knowledge and obvious eﬀects
of CMS on the function of NMJs and whole skeletal muscles, little is
known about the speciﬁc and long-term changes that suboptimal cholinergic transmission causes on muscle ﬁbers. In this study, we examined skeletal muscles with varying functional demands and diﬀerent
muscle ﬁber composition in VAChT-KDHOM mice. We also assessed if
pathogenic features resembling CMS are reversible in adult skeletal
muscles of VAChT-KDHOM mice.

transmission is Vesicular Acetylcholine Transporter (VAChT), encoded
by the SLC18A3 gene. Mutations in this gene were recently identiﬁed in
patients presenting with diﬀering degrees of myasthenia (OMIN
number: # 617239) (Aran et al., 2017; O'Grady et al., 2016; Schwartz
et al., 2018). VAChT functions to move acetylcholine (ACh) into synaptic vesicles (Kljakic et al., 2017; Parsons, 2000; Prado et al., 2013)
following its synthesis by choline acetyltransferase (ChAT). Under
steady-state conditions, VAChT transports suﬃcient ACh into synaptic
vesicles to activate acetylcholine receptors (AChRs) on the muscle ﬁber
membrane to promote muscle contraction (Katz and Miledi, 1964;
Langley, 1907). However, mutations in VAChT (de Castro et al., 2009;
Prado et al., 2006) reduce the amount of ACh loaded into synaptic
vesicles, thus impairing AChR activation and muscle contraction.
In addition to causing CMS, loss of ACh aﬀects the formation and
development of muscle ﬁbers and their NMJs (Darabid et al., 2014;
Gautam et al., 1999; Miner et al., 1998). Highlighting this point, deletion of ChAT or VAChT in mice aﬀects the morphology and function of
nascent NMJs and muscle ﬁbers, and invariably results in early postnatal death due to lack of cholinergic transmission (Brandon et al.,
2003; de Castro et al., 2009; Misgeld et al., 2002). To further assess the
contribution of ACh to NMJ and muscle development, transgenic mice
with reduced expression of VAChT were generated and examined in
previous published studies. This involved introducing a selection
marker cassette within the 5′untranslated region of the VAChT gene to
interfere with VAChT expression (Prado et al., 2006) using homologous
recombination. Transgenic mice with both VAChT gene locus modiﬁed
are referred to as VAChT-KDHOM. These mice present with 65% reduction in VAChT levels, shown using qPCR and western blot analysis,
yet survive and reach adulthood despite having a pronounced deﬁcit in
neuromuscular transmission and function (Lima et al., 2010; Prado
et al., 2006; Rodrigues et al., 2013). VAChT-KDHOM also exhibit cardiac
dysfunction (Lara et al., 2010), increased inﬂammatory responses (Leite
et al., 2016), and cognitive impairment (Prado et al., 2006). Thus, the
phenotypes described in VAChT deﬁcient mice closely resemble phenotypes found in human patients with VAChT mutations, suggesting a
high degree of functional conservation and further indicating that low
levels of ACh causes CMS in VAChT transgenic mice (Aran et al., 2017;
O'Grady et al., 2016).
Although pre-synaptic alterations in adult VAChT-KDHOM mice have
been reported (Lima et al., 2010; Prado et al., 2006; Rodrigues et al.,
2013), it is still unknown whether long-term changes in cholinergic
activity due to VAChT deﬁciency causes long-term changes in the
structure and function of skeletal muscles. In most mammals, adult
skeletal muscles are populated by four types of muscle ﬁbers, which can
be identiﬁed based on the expression of Myosin Heavy Chain (MyHC)
isoforms. The four types of MyHC are: type 1 or slow-oxidative ﬁbers;
2A or fast oxidative-glycolytic; and 2X and 2B, which are fast-glycolytic
ﬁbers. The unique metabolic and contractile properties of these muscle
ﬁbers underlie the diﬀerent functional outputs of skeletal muscles
(Bloemberg and Quadrilatero, 2012; Brooke and Kaiser, 1970;

2. Materials and methods
2.1. Experimental design
The generation and genotyping of VAChT-KDHOM transgenic mice
was previously described (Prado et al., 2006). VAChT-KDHOM mice have
a 65% reduction in VAChT expression. All animals were genotyped 10
days after birth. VAChT-KDHOM mice were obtained by intercrossing
heterozygous animals. Control mice were wild type (WT) age and sexmatched littermates. We only examined male adult (3-6 months-old)
mice in this study. Animals were housed in an animal care facility in
Department of Physiology and Biophysics, Universidade Federal de
Minas Gerais (UFMG). Animals were grouped with three to ﬁve animals
into mini-isolator cages (length: 48,3 cm; width: 33,7 cm; height:
21,4 cm- Alesco®) in a temperature-controlled room (∼24 °C) with a
12:12 light-dark cycles, with food (Nuvilab CR-1) and water provided
ad libitum. Mice weight was approximately 28.6 ± 2.8 g for WT and
24.2 ± 2.7g for VAChT-KDHOM mice (see Table 3). The experimental
procedures were carried out in accordance with the protocol approved
by the UFMG ethics committee (CEUA, protocol 40/2009) and in accordance with NIH and ARRIVE guidelines for the Care and Use of
Animals in Research and Teaching. All eﬀorts were made to minimize
animal suﬀering and to reduce the number of animals used.
All animals used in this study were appropriately identiﬁed by
numbers according to their genotype (WT or VAChT-KDHOM). Using the
genotyping table, animals were randomly divided into the following
groups: Group one, untreated: WT and VAChT-KDHOM; Group two
treated with Pyridostigmine (PYR): WT, WT PYR, VAChT-KDHOM and
VAChT-KDHOM PYR. Animals were randomly treated and evaluated.
The animals assigned to group one were deeply anesthetized by
inhalation of isoﬂurane in a glass chamber or with ketamine/xylazine
(0.1 mL/20 g). All procedures were performed in accordance to the
CEUA/UFMG protocol. All surgical procedures are described in the
appropriated sections. The experimental procedures were mostly performed in the afternoon, and by the end of each surgical procedure
animals were euthanized using a super-dosage of anesthetics. The experiments were conducted at the Department of Morphology and
Physiology on Federal University of Minas Gerais. The exact numbers
for all experiments are provided in the ﬁgure legends and results
2
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Table 1
Quantitative analyses of the EDL muscle from WT and VAChT-KDHOM mice.

Table 2
Quantitative analyses of the soleus muscle from WT and VAChT-KDHOM mice.

EDL

WT

VAChT-KDHOM

Statistics
(p < 0.05)

Soleus

WT

VAChT-KDHOM

Statistics
(p < 0.05)

Whole muscle
area
(mm2)
Total number
of ﬁbers
Mean ﬁbers
CSA (μm2)
Type 2A CSA
(μm2)
Type 2X CSA
(μm2)
Type 2B CSA
(μm2)
% of type 2A
% of Type 2X
% of Type 2B

1.8 ± 0.06

1.4 ± 0.06*

p = 0.0016

1.45 ± 0.12

1.5 ± 0.09

NS

856.2 ± 22.8

730.3 ± 28.19*

p = 0.009

979 ± 74.5

778 ± 22.6*

p = 0.0140

1525 ± 45.4

1777 ± 51.1*

p = 0.005

1735 ± 91.2

1429 ± 55.6*

p = 0.016

1691 ± 75.6

1960 ± 92.3*

p = 0.04

640.5 ± 35.1

540.3 ± 42.7

NS

1349 ± 11.6

1745 ± 54.4*

P < 0.0001

892.4 ± 50.9

700.9 ± 47.2*

p = 0.02

1652 ± 109.1

1727 ± 55.7

NS

2344 ± 67.7

1758 ± 58.8*

p = 0.0002

5.6 ± 0.7
16.3 ± 1.4
74 ± 2.6

8.4 ± 1.03
25.9 ± 1.1*
64.6 ± 2.06*

NS
p = 0.0008
p = 0.04

Whole muscle
area (mm2)
Total number of
ﬁbers
Mean ﬁbers
CSA (μm2)
Type 1 CSA
(μm2)
Type 2A CSA
(μm2)
Type 2X CSA
(μm2)
% of type 1
% of Type 2A
% of Type 2X

34.8 ± 2.7
54.1 ± 2.4
11.1 ± 2.4

43.8 ± 1.03*
46.5 ± 1.8*
9.7 ± 2.01

p = 0.007
p = 0.03
NS

VAChT-KDHOM

WT

VAChT-KDHOM

Statistics
(p < 0.05)

Molecular
markers
(2−ΔΔCT)

WT

Molecular
markers
(2−ΔΔCT)

Statistics
(p < 0.05)

Atrogin-1
MuRF-1
Pax-7
MyoD
Myogenin
PGC1-α
MTND1

0.0089 ± 0.0013
0.0128 ± 0.002
0.0003 ± 0.00002
0.0012 ± 0.0002
0.00036 ± 0.00002
0.0026 ± 0.0001
4.88 ± 0.75

0.004 ± 0.0009*
0.0114 ± 0.0021
0.0003 ± 0.00003
0.0002 ± 0.00003*
0.00019 ± 0.00001*
0.0019 ± 0.0001
3.14 ± 0.36*

p = 0.02
NS
NS
p = 0.0005
p = 0.0003
NS (p = 0.06)
p = 0.047

Atrogin-1
MuRF-1
Pax-7
MyoD
Myogenin
PGC1-α
MTND1

0.0055 ± 0.0009
0.0122 ± 0.0015
0.0005 ± 0.00008
0.0002 ± 0.00002
0.0008 ± 0.0001
0.0038 ± 0.0003
8.39 ± 0.76

0.0094 ± 0.0009*
0.0173 ± 0.001*
0.00146 ± 0.0001*
0.0004 ± 0.00002*
0.001 ± 0.0001
0.0081 ± 0.001*
13.04 ± 0.89*

p = 0.02
p = 0.02
p = 0.0008
p = 0.001
NS#
p = 0.004#
p = 0.003

Statistical analysis was deployed to compare morphological diﬀerences between 6 WT and 7 VAChT-KDHOM mice. The average whole muscle area and
variability was compared between genotypes. For individual muscle ﬁber crosssectional area (CSA) analysis, we evaluated a total of 2835 muscle ﬁbers per
genotype: 1104 for type 1, 1186 for type 2A, and 397 for type 2X. Values represent Mean ± SEM. Unpaired Student's t-test was applied after the data was
analyzed by the Kolmogorov-Smirnov normality test. Molecular analysis was
performed in 6 WT and 6 VAChT-KDHOM mice. * Statistically diﬀerent from WT
mice. # Mann-Whitney test for non-Gaussian data set. NS: Not Signiﬁcant.

Statistical analysis was deployed to compare morphological diﬀerences between 5 WT and 7 VAChT-KDHOM mice. The average whole muscle area and
variability was compared between genotypes. For individual muscle ﬁber crosssectional area (CSA) analysis, we evaluated a total of 2767 ﬁbers per genotype:
316 for type 2A, 544 for type 2X, and 1907 for type 2B. Molecular analysis was
performed in 3 WT and 6 VAChT-KDHOM mice. Values represent Mean ± SEM.
Unpaired Student's t-test was applied after the data was analyzed using
Kolmogorov-Smirnov normality test. * Statistically diﬀerent from WT mice. #
Mann-Whitney test for non-Gaussian data set. NS: Not Signiﬁcant.

Table 3
Results of the maximal incremental test.

section. The experimental groups remained constant from the beginning to the end of the study.
2.2. Morphological and morphometrical analyses
Mice were anesthetized with isoﬂurane, followed by cervical dislocation. The gastrocnemius, extensor digitorum longus (EDL) and soleus muscles were surgically excised, ﬁxed in 4% glutaraldehyde for
24 h, dehydrated in an ascending volumes of alcohol (70%, 80%, 90%,
95% 2X), embedded in glycol methacrylate resin (Leica), and cut in a
microtome (Reichert Jung). The mid-belly regions of muscles were cut
into 3–5 μm thick sections. Muscle sections were stained with toluidine
blue (EMS) for cross-sectional area (CSA) analysis of individual myoﬁbers. Images were acquired using a microscope (Zeiss Axiolab A1)
coupled to a CCD camera, visualized in a computer and analyzed using
the Axiovision (Zeiss) or Image J (NIH) where a polygon selection tool
was used to manually draw a perimeter around muscle ﬁbers to determine the CSA of individual myoﬁbers. The average CSA for gastrocnemius muscle ﬁbers were calculated from at least 500 individual
muscle ﬁbers per animal per genotype.

MIT TEST

WT

VAChT-KDHOM

Statistics

Body weight (g)
Distance (m)
Vmax (cm/s)
Duration (min)
VO2 Basal (ml.Kg-1.min-1)
VO2 Max (ml.Kg-1.min-1)
Work (J)

28.6 ± 2.7
417.3 ± 132.6
31.2 ± 4.02
26.8 ± 4.4
15.1 ± 6.1
29.9 ± 5.4
21.1 ± 7.5

24.25 ± 2.6*
105.4 ± 37.6*
15.5 ± 2.2*
10.6 ± 2.4*
13.4 ± 4.3
25.8 ± 4.2
3.3 ± 0.7*

p = 0.03
p = 0.0004
p < 0.0001
p < 0.0001
NS
NS
p = 0.0003

Statistical analysis was deployed to compare diﬀerences between 5 WT and 6
VAChT-KDHOM mice. The average whole muscle area and variability was
compared between genotypes. Values represent Mean ± SEM. *Statistically
diﬀerent from WT mice based on Unpaired Student's t-test. NS: Not Signiﬁcant.

frozen in isopentane (Sigma-Aldrich), cooled in liquid nitrogen, and
stored at −80 °C. The mid-belly region of muscles was cut on a cryostat
(Leica CM3050S), and cross sections (10 μm) were collected on gelatincoated slides. Muscle sections were blocked 30 min at room temperature (RT) with 3% BSA (Sigma-Aldrich), 5% goat serum (Sigma-Aldrich), and 0.1% Triton X-100 (Sigma-Aldrich) diluted in PBS 1x.
Muscle sections were then incubated overnight (ON) at 4 °C with the
following primary antibodies (diluted in 3% BSA, 5% goat serum), all
raised in mice: type 1 (Leica Microsystems Cat# NCL-MHCs Lot#
RRID:AB_563898; 1:250); type 2A (DSHB Cat# SC-71 Lot# RRID:AB_
2147165; 1:100), type 2X (DSHB Cat# BF-35 Lot# RRID:AB_2274680,
which recognizes all types of muscles ﬁbers except for the 2X; 1:100),
and type 2B (DSHB Cat# BF-F3 Lot# RRID:AB_2266724; 1:100). SC-71,

2.3. Myosin heavy chain isoforms staining
Myosin heavy chain isoforms were identiﬁed according to the protocol described by Valdez et al. (2012). Mice were sacriﬁced, and then
EDL, gastrocnemius and soleus muscles were collected, immersed in
OCT (Easy Path), oriented in freezing molds, and covered with freezing
medium. The EDL and Soleus were put in the same mold and freshly
3
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paraformaldehyde and 2.5% glutaraldehyde in 0.1 M sodium cacodylate buﬀer) and maintained in this solution for at least 24 h at 4 °C. After
ﬁxation, samples were washed with cacodylate buﬀer (0.1 M- EMS), cut
into several pieces, post-ﬁxed in reduced osmium (1% osmium tetroxide in cacodylate buﬀer containing 1.6% potassium ferrocyanideEMS), contrasted en bloc with uranyl acetate (2% uranyl acetate in
deionized water- EMS), dehydrated through an ascending series of
ethanol solutions followed by acetone and embedded in EPON 812 resin
kit (EMS). Blocks were sectioned (50 nm) and collected on 200 or 300
mesh copper grids and contrasted with lead citrate (EMS). Sections
were viewed with a Tecnai- G2-Spirit-FEI/Quanta electron microscope
(120 kV Philips) located at Microscopy Center – UFMG.

BF-35 and BF-F3 antibodies were deposited to the DSHB by Stefano
Schiaﬃno. Slides were washed three times with PBS 1x and incubated
for 1 h at room temperature with secondary antibodies: Alexa 488 goat
anti-mouse IgG1 (Thermo Fisher Scientiﬁc Cat# A-21121 Lot#
RRID:AB_2535764. Recognizes the type 1, 2A and 2X antibodies) and
Alexa 488 goat anti-mouse IgM (Thermo Fisher Scientiﬁc Cat# A-21042
Lot# RRID: AB_2535711. Recognizes type 2B antibody). The slides
were washed 3 times again with PBS 1x and mounted using VectaShield
anti-fade solution (Vector Laboratories Cat# H-1000 Lot# RRID:AB_
2336789). Images were acquired using an air objective (10x, 0.25NA)
in a ﬂuorescence microscope (Leica DM2500) coupled to a Leica DFC
345FX camera and visualized in a computer. Excitation light came from
a 100W Hg lamp, and an FITC ﬁlter was used to collect emitted light.
Whole muscle cross sections were imaged for analysis. Each ﬁber type
was expressed as a percentage of the total number of ﬁbers counted in a
whole muscle section. Stained sections were also used to analyze the
CSA of type identiﬁed muscle ﬁbers. Each antibody was validated using
appropriate negative controls, which included sections not incubated
with primary antibodies (data not shown).

2.6. Behavioral tests
2.6.1. Open ﬁeld
The open ﬁeld test was used to analyze spontaneous locomotor
activity (Ferreira-Vieira et al., 2014; Sousa et al., 2006). The test was
performed in a box (50 × 50 cm) with the ﬂoor divided into 16 equal
squares. The mice were individually placed in the back corner of the left
side and allowed to explore the open ﬁeld for 300s. The spontaneous
locomotor activity was measured using sensors located at the base of
the boxes connected to a computer where a software automatically
determined the number of segments crossed, known as crossing (horizontal locomotion) (Vianna et al., 2000).

2.4. Reverse transcription and qPCR
The EDL and soleus muscles were rapidly removed from animals,
immersed in RNA latter solution (Sigma-Aldrich) to avoid RNA degradation, and stored for 24 h at 4 °C and at −20 °C until processing.
Total RNA was extracted using TRIzol reagent (Invitrogen, San Diego,
CA) and treated with DNAse Ampliﬁcation Grade (RNase-free) (Sigma
AMP-D1). After reverse transcription (RT-PCR) using the M-MLV enzyme (M-MLV RT, Promega, M1705), 40 ng of the generated cDNA was
used for qPCR. The endogenous GAPDH (internal control) Fw: TGCG
ACTTCAACAGCAACTC; Rv: ATGTAGGCCATGAGGTCCAC; Myogenin
Fw:
CACTCCCTTACGTCCATCGT;
Rv:CAGGACAGCCCCACTTA
AAA;MyoDFw:GGCCACTCAGGTCTCAGGTGT;Rv:TGTTGCACTACACA
GCATGCCT; Pax-7 Fw: AAAAGCACCAAGCCAAGACC; Rv: GCACACAT
CCCACTCACACC; PGC1-α1 Fw: CCCTGCCATTGTTAAGACC; Rv: TGC
TGCTGTTCCTGTTTTC; MTND-1 Fw: GTTGGTCCATACGGCATTTT; Rv:
TGGGTGTGGTATTGGTAGGG; Atrogin1 Fw: GCAGAGAGTCGGCAA
GTC; Rv: CAGGTCGGTGATCGTGAG and MuRF1 Fw: TGGAAACGCTA
TGGAGAACC; Rv: ATTCGCAGCCTGGAAGATG were ampliﬁed. SYBR
green reagent (SYBR® Green PCR Master Mix, Applied Biosystems) was
used in ViiA™ 7 System (Applied Biosystems) real-time cycler that allows automatic melting curve analysis. A single melt peak for each
reaction conﬁrmed the identity of each PCR product. The relative
comparative Cycle Threshold (CT) method was applied to compare
gene expression levels between groups, using the equation (2)−ΔΔCT
(Pcr and Pfaﬄ, 2001). The expression level of WT and VAChT-KDHOM
genes were normalized to GAPDH as an internal control and no differences were found in GAPDH CTs between EDLs from WT and VAChTKDHOM mice. Myogenin (WT: 13.2 ± 0.1 and VAChT-KDHOM:
13.2 ± 0.28). MyoD (WT: 13.1 ± 0.1 and VAChT-KDHOM:
13.1 ± 0.27). MTND-1 and Pax-7 (WT: 13.4 ± 0.1 and VAChTKDHOM: 13.9 ± 0.32). Atrogin-1, MuRF-1 and PGC1-α (WT:
13.4 ± 0.08 and VAChT-KDHOM: 14 ± 0.38). Soleus: Myogenin (WT:
14.8 ± 0.3 and VAChT-KDHOM: 14.1 ± 0.2). MyoD (WT: 14.5 ± 0.3
and VAChT-KDHOM: 14 ± 0.2). MTND-1 and Pax-7 (WT: 14.8 ± 0.3
and VAChT-KDHOM: 14.4 ± 0.2). Atrogin-1, MuRF-1 and PGC1-α (WT:
14.7 ± 0.3 and VAChT-KDHOM: 14.1 ± 0.2). Expression changes reﬂect fold diﬀerences between WT mice (control) and VAChT-KDHOM
mice. RNA sequences are available at GenBank data base in: (https://
www.ncbi.nlm.nih.gov/genbank/).

2.6.2. Wire-hang
The wire-hang test is a useful tool to evaluate motor strength in
rodents, and the experiments were performed according to Sango et al.
(1996) and Prado et al. (2006). Mice were habituated at the behavioral
room 2 h before the test. We placed each animal individually in the top
of a wire cage lid (22 × 22 cm) and then the lid was gently turned
upside down by the investigator. The latency of mice to lose their grip
and fall oﬀ the lid was visually evaluated in three trials with a cutoﬀ
time of 60s.
2.6.3. Rotarod
The rotarod test was used to assess motor coordination in our experimental model (Ingram et al., 1981). The apparatus consists of a
rotating cylinder. The time animals take to fall from the rotating rod is
registered automatically. We used the protocol described by Prado et al.
(2006) with minor modiﬁcations to account for the age of the mice
tested in this study. First, mice were acclimated three consecutive days
to the rotarod apparatus (Insight Equipments, Ribeirão Preto, Brazil)
with the device turned oﬀ. Second, each mouse was gently placed on
the rod, and the rotation speed was set to 7 rpm. The training session
consisted of three trials. Four hours later, animals were tested using a
non-accelerating protocol (rotation maintained at 7 rpm). The performance of each animal on the rotarod represents the average of three
independent tests.
2.7. Maximal incremental test (M.I.T)
An electric treadmill (EP - 132 - INSIGHT, Ribeirão Preto, Brazil)
was used to evaluate mice maximal aerobic capacity. The initial speed
was set at 10 cm per seconds (cm/s) for 5 min through ﬁve days
(Familiarization Period). The Maximal Incremental Test (MIT) starts
with the speed at 10 cm/s then increases 5 cm/s every 3 min, at a 5%
grade, until the animal stops running and is fatigued. Fatigue is deﬁned
by the refusal of the mouse to continue moving on the treadmill belt
more than 10 s. A mild electrical stimulus (0.2 mA) was applied to the
mice that stepped oﬀ the treadmill to keep them exercising. For oxygen
consumption mice were weighed and placed individually into the gas
chamber coupled to the test treadmill using continuous recorders of
oxygen consumption (VO2) with an open-ﬂow indirect calorimeter
(LE405 Gas Analyzer, Panlab Harvard Apparatus, Spain). VO2 (mlO2/

2.5. Transmission electron microscopy (TEM)
For ultrastructure analyses, we used the protocol described by
Rodrigues et al. (2013). Brieﬂy, EDL and soleus muscles from WT and
VAChT-KDHOM were ﬁxed by ice-cold modiﬁed Karnovsky ﬁxative (4%
4

Neurochemistry International 120 (2018) 1–12

M.P.S. Magalhães-Gomes et al.

distribution. One-way ANOVA or Kruskal-Wallis, and a post hoc
Newman Kulls or Dunn's multiple comparison test was performed when
appropriate, as described in the text. Values of p ≤ 0.05 were considered signiﬁcant. All behavioral, molecular, electron microscopy and
maximal incremental tests experiments were conducted with researchers “blind” to the genotypes of the mice, except for histological
and ﬁber typing analysis. Each genotyped animal was assigned a code
that was revealed to the investigator after completing analysis. In this
work we used between n = 3–7 animals per genotype for each data set
to detect a diﬀerence at 95% conﬁdence interval (a = 0.05) and 0.8
power. The exact n for each experimental procedure is described in the
ﬁgure legends, as well as p values. All data points were treated as
outliers and excluded from the data analysis using the Graph Pad
QuickCalcs outlier calculator available at (https://graphpad.com/
quickcalcs/Grubbs1.cfm).

kg/min) was continuously recorded on-line, every minute at rest and
during the fatiguing exercise protocol (exercise protocol) and then
analyzed using a computerized system (Metabolism V 2.2.01, Harvard
Apparatus, Spain). In the ﬁrst 30 min, the animals were placed in the
treadmill coupled to a gas chamber for measurements of the basal VO2.
Immediately after this time, the treadmill was turned on and mice
started to run following the test protocol. At the end of the test the VO2
peak was selected for analysis. Workload (W) was calculated as
W = [body weight (kg)] × [time to fatigue] × [treadmill speed (m/
min)] × [sin θ (treadmill inclination)].
2.8. Pharmacological treatment
Six month old WT and VAChT-KDHOM mice were treated with the
acetylcholinesterase inhibitor pyridostigmine (Sigma-Aldrich) (i.p.,
1 mg/kg) for 28 days with two doses per day, according to Prado et al.
(2006). At the end of the treatment period, animals were sacriﬁced,
then EDL and soleus muscles were excised for histology analysis as
described above.

3. Results
First, we evaluated the long-term eﬀects of decreased ACh on the
morphology of muscle ﬁbers in the gastrocnemius muscle.
Gastrocnemius muscle cross-sections from VAChT-KDHOM and wild type
(WT) mice were stained with antibodies against diﬀerent ﬁber types
and with toluidine blue to visualize muscle ﬁber subtypes and their
cross-sectional area (CSA), respectively (Fig. 1A–B). We found that
muscle ﬁbers in the gastrocnemius muscle of VAChT-KDHOM are on
average 14% smaller compared to WT mice (Fig. 1C–D). We also found
fewer type 2B ﬁbers in the gastrocnemius muscles of VAChT-KD mice
(28 ± 1.46%) compared to WT (48.4 ± 5.07%). Interestingly, we
found more type 2X in VAChT-KDHOM mice (34.7 ± 5.1%) compared

2.9. Statistical analysis
All data were analyzed using Microsoft Excel and GraphPad Prism 5.
The histology data represent the mean ± SEM of least 500 muscle ﬁbers CSA summarized in tables. Before deﬁning the statistical tests, data
was evaluated by the Kolmogorov-Smirnov normality test to address
whether or not the data followed a Gaussian distribution. Statistical
signiﬁcance was evaluated using the unpaired Student's t-test when
data was normally distributed or Mann-Whitney test for non-Gaussian

Fig. 1. Gastrocnemius muscle from VAChT-KDHOM mice are atrophied and exhibit ﬁber type shift. A-B: Representative images of the whole gastrocnemius
muscle stained for the diﬀerent ﬁber types (A) cross-section of ﬁbers marked with toluidine blue (B), showing smaller muscle ﬁbers in the VAChT-KDHOM mice (B)
when compared with WT. Scale bar = 1000 μm (A) 50 μm (B). C: Frequency distribution histogram of gastrocnemius muscle ﬁbers Cross-Sectional-Area (CSA). D:
CSA mean values for VAChT-KDHOM mice compared with WT mice (*p < 0.05; one-tailed unpaired Student t-test, n = 3 animals per genotype). E: Fiber type
analysis showing reduced type 2B and increase in type 2X ﬁbers in VAChT-KDHOM mice. We analyzed one muscle cross-section for each animal, and a total of 3152
myoﬁbers were evaluated for both genotypes (*p < 0.05; Unpaired Student t-test, n = 3 animals per genotype. In D and E, values represent mean ± SEM). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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to WT (14.2 ± 1.91%). We next examined muscle ﬁbers in the predominantly fast-twitch extensor digitorum longus (EDL) muscle. Muscle
ﬁbers in the EDL were on average 22% smaller in VAChT-KDHOM mice
compared to WT (Fig. 2A and Table 1). This overall reduction in muscle
ﬁber size was due to decreased CSA in types 2X and 2B ﬁbers in the EDL
of VAChT-KDHOM (Fig. 2B–D and Table 1). The EDL muscle is composed
mainly of fast-glycolytic muscle ﬁbers (type 2X and 2B) and few fast
oxidative-glycolytic muscle ﬁbers (type 2A) (Bloemberg and
Quadrilatero, 2012). Interestingly, the EDL muscles in VAChT-KDHOM
mice also have fewer muscle ﬁbers (Table 1), suggesting that either
muscle ﬁbers failed to form or degenerate postnatally. Based on this
observation, we determined the number of each muscle ﬁber type populating the EDL muscle in VAChT-KDHOM and WT mice. While Type 2B
ﬁbers were reduced, type 2X ﬁbers were increased in VAChT-KDHOM
mice compared with WT mice (Table 1). This analysis showed similar
numbers of type 2A muscle ﬁbers between genotypes demonstrating
that these changes were speciﬁc to fast glycolytic muscle ﬁbers (2B and
2X). The shifts in type 2X/2B ratio in the gastrocnemius and EDL
muscles suggest that reduced cholinergic transmission either causes

type 2B to dediﬀerentiate into type 2X or slows the diﬀerentiation of
type 2X into type 2B muscle ﬁbers.
The reduced size and number of muscle ﬁbers in the EDL muscle of
VAChT-KDHOM mice also indicates that reduced cholinergic transmission results in the activation of pro-atrophy genes. To look into this
possibility, we examined levels of Atrogin-1 and MuRF1, both involved
in the activation of the ubiquitin-proteasome system (Sacheck et al.,
2004). Unexpectedly, Atrogin-1 is reduced and MuRF-1 remains unchanged in the EDL muscle of VAChT-KDHOM compared with WT mice
(Table 1). We then examined levels of Pax-7, Myogenin, and MyoD,
three genes important for muscle biogenesis and maintenance. We
found MyoD and Myogenin reduced in the EDL muscles of VAChTKDHOM mice (Table 1). However, levels of Pax-7 remain unchanged in
the EDL muscles of VAChT-KDHOM mice (Table 1). Next, we examined
levels of two mitochondria-related genes important in skeletal muscles.
PGC1-α promotes mitochondrial biogenesis (Yoon et al., 2001) and
MTND-1 is a mitochondrial DNA (mtDNA) encoding complex I gene
associated with mitochondrial respiratory chain (Mimaki et al., 2012).
No signiﬁcant diﬀerence was found in PGC1-α expression between

Fig. 2. Fast-twitch EDL from VAChT-KDHOM mice shows reduction of whole muscle area, ﬁber type atrophy and ﬁber type shift. A: Images of the whole EDL
muscle from WT and VAChT-KDHOM mice labeled with type 2B antibody showing reduced CSA. Scale bar = 0.5 mm2. B: Representative images from sections of EDL
from WT and VAChT-KDHOM mice stained with toluidine blue showing increased number of small muscle ﬁbers in the VAChT-KDHOM mice compared with WT. Scale
bar = 50 μm. C: Images of the EDL from WT and VAChT-KDHOM mice labeled with antibodies against diﬀerent ﬁber types showing reduced type 2B and increased
type 2X ﬁbers expression in VAChT-KDHOM. Scale bar = 50 μm. D-G: Histogram of CSA values showing increased number of small muscles ﬁbers in EDL from VAChTKDHOM mice. For cross-sectional area (CSA) muscle analysis we evaluated a total of 2767 ﬁbers: 316 for type 2A, 544 for type 2X, and 1907 for type 2B n = 5 WT and
7 VAChT-KDHOM mice. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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VAChT-KDHOM mice and WT mice (Table 1). However, MTND-1 was
reduced by 36% in VAChT-KDHOM mice (Table 1). These ﬁndings show
that myogenesis and mitochondria function are impaired, and potentially contribute to the decreased number and size of muscle ﬁbers in
the EDL muscles of VAChT-KDHOM mice.
The soleus muscle is quite diﬀerent from the EDL muscle in several
respects. It is primarily composed of slow-twitch muscle ﬁbers, it is
tonically active, and functions in maintaining posture (Di Giulio et al.,
2009). We thus asked if reducing ACh levels has a similar eﬀect on the
soleus as observed above in the EDL muscles. In stark contrast to the
EDL muscle, we found that muscle ﬁbers are approximately 11% larger
in the soleus muscle of VAChT-KDHOM mice compared to WT mice
(Fig. 3D and Table 2). Both type 1 and 2A muscle ﬁbers were enlarged
by 8% and 17%, respectively in VAChT-KDHOM mice compared to WT
mice (Fig. 3C–G and Table 2). Moreover, the ratio of type 1 to type 2A
muscle ﬁber is higher in the soleus muscle of VAChT KDHOM compared
to WT mice (Table 2). Despite the increased size of muscle ﬁbers, the
overall size of the soleus muscle was indistinguishable between VAChTKDHOM and WT mice (Fig. 3A and Table 2). The overall size of the

soleus muscle remains unchanged because it contains fewer, yet larger,
muscle ﬁbers in VAChT-KDHOM compared to WT mice (Table 2).
To further examine the impact of reducing ACh on the soleus
muscle, we again assessed expression levels of genes associated with
muscle atrophy, biogenesis, and maintenance. In contrast to the EDL
muscle, Atrogin-1 and MuRF1 levels are 1.7 and 1.4 fold higher, respectively, in VAChT-KDHOM mice (Table 2). Likewise, Pax-7 and MyoD
are 2.9 and 2 fold higher, respectively, in the soleus muscle of VAChTKDHOM mice (Table 2). Additionally, the metabolic modulators, PGC1-α
and MTND-1, are both increased in the soleus muscle of VAChT-KDHOM
mice (Table 2). Together, these data show that decreasing ACh levels
has a diﬀerent eﬀect on the soleus muscle, and particularly on type 1
muscle ﬁbers, compared to the EDL muscle and fast type muscle ﬁbers.
We used transmission electron microscopy (TEM) to visualize the
subcellular composition of slow and fast-twitch muscles under reduced
cholinergic transmission. In the EDL muscle of WT mice, as expected,
the Z-line (white arrows) (Fig. 4A), triads (sarcoplasmic reticulum- SR
and T-tubules) (white arrows-head) (Fig. 4B), mitochondria (red arrows-head) (Fig. 4B), and sarcomeres (red asterisks) (Fig. 4B) appear

Fig. 3. Slow-twitch soleus from VAChT-KDHOM mice shows muscle ﬁbers hypertrophy and ﬁber type shift. A: Images of the whole soleus muscle from WT and
VAChT-KDHOM mice labeled with type 1 antibody. No changes were observed. Scale bar = 0.5 mm2. B: Representative images from sections of soleus from WT and
VAChT-KDHOM mice stained with toluidine blue. Traced rectangle shows newly formed muscle ﬁbers. Scale bar = 50 μm. C: Images of the soleus from WT and
VAChT-KDHOM mice labeled with antibodies against diﬀerent ﬁber types showing increased type 1 and reduced type 2A ﬁbers expression in VAChT-KDHOM. Scale
bar = 50 μm. D-G: Histogram of CSA values showing increased number of muscle ﬁbers with larger CSA in soleus from VAChT-KDHOM mice. For cross-sectional area
(CSA) muscle analysis we evaluated a total of 2835 ﬁbers: 1104 for type 1, 1186 for type 2A, and 397 for type 2X n = 6 WT and 7 VAChT-KDHOM mice. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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Fig. 4. Myoﬁbrils of the fast-twitch EDL from VAChT-KDHOM mice show signs of degeneration while slow-twitch soleus is preserved. A-B: Images in the
upper and lower panels are 16,500x and 26,500x, respectively. A: Representative images of the EDL muscle ﬁbers from WT showing correct alignment of the Z-lines
(white arrows) (A), normal triads (white arrows-head) (B), normal-shaped mitochondrial proﬁles (red arrows-head) (B), normal sarcoplasmic reticulum located
between myoﬁbrils (yellow arrows-head) and preserved sarcomere (red asterisk) (B). C-D: Representative images of EDL muscle ﬁbers from VAChT-KDHOM mice
showing myoﬁbrils disruption (red asterisks) (D), abnormal elongated T-tubules (white arrows-head) (D), abnormal and misplaced SR (yellow arrows-head),
elongated mitochondrial proﬁles associated to degenerated regions (red arrows-head). Normal sarcomere in C. E – F: Representative images of the soleus from WT
showing preserved muscle ﬁbers. Alignment of Z-lines (E) (white arrows), normal size mitochondrial proﬁles (F) (red arrows-head), and regular sarcomere (F) (red
asterisks). G – H: The soleus from VAChT-KDHOM, shows preserved sarcomeres (red asterisks). The mitochondrial proﬁles from VAChT-KDHOM mice are more frequent
(H) (red arrows-head). We evaluated at least 15 images from three diﬀerent animals for each genotype. Scale bar = 500 nm. (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the Web version of this article.)

normal. In contrast, muscle ﬁbers of the EDL from VAChT-KDHOM mice
present discontinuous Z-lines (white arrows) (Fig. 4C) and disruption of
myoﬁlaments (separation of the thin and thick myoﬁlaments) of some
sarcomeres (red asterisks) (Fig. 4D). Quantitatively, the number of
disrupted sarcomeres is 6.2 times higher in VAChT-KDHOM mice compared to WT mice (WT: 5.7 ± 3.3 and VAChT-KDHOM: 35.6 ± 9.1%,
p = 0.03). These muscle ﬁbers also exhibit abnormal T-tubules, which
are more elongated than normal, and lack typical triads (white arrowshead) (Fig. 4D). The SR also exhibits abnormal, swelled, and misplaced
vacuole-like structures (yellow arrows-head) (Fig. 4D). Moreover, we
found elongated mitochondrial proﬁles located in the regions of muscle
ﬁbers associated with degraded myoﬁbril regions (red arrows-head)
(Fig. 4D). In stark contrast to the EDL muscle, ﬁbers in the soleus
muscle from VAChT-KDHOM mice exhibit preserved components, such

as correct alignment and continuity of the Z-lines (white arrows)
(Fig. 4E–G), and sarcomere integrity (red asterisk) (Fig. 4F–H). In
agreement with increased PGC1-α and MTND-1 levels, mitochondria
are more prevalent in muscle ﬁbers in the soleus muscle of VAChTKDHOM compared to WT mice (Fig. 4G–H).
To assess the function of the gastrocnemius, soleus, and EDL muscles, we performed a series of behavior and oxygen consumption tests in
VAChT-KDHOM and WT mice. Oxygen consumption while resting and
under maximal intensity was measured using a maximal incremental
test (MIT). The duration, distance, maximum velocity (Vmáx), the
work, and oxygen handling parameters were evaluated. We found a
signiﬁcant reduction in the MIT duration and distance (Table 3) in
VAChT-KDHOM mice. The maximum velocity is also reduced (Table 3).
Additionally, the work performed is signiﬁcantly reduced in VAChTFig. 5. Pyridostigmine (PYR) treatment partially reverses
morphology alterations in EDL and soleus muscles in
VAChT-KDHOM mice. A-B: Images of EDL (A) and soleus (B)
muscle ﬁbers from WT and VAChT-KDHOM mice treated and
non-treated with PYR. C. Cumulative frequency of muscle
ﬁbers areas of the EDL from WT and VAChT-KDHOM mice
showing VAChT-KDHOM-PYR partially restoring muscle ﬁbers
to WT values. D. In the Soleus, VAChT-KDHOM-PYR partially
restored the sizes of its muscle ﬁbers. For the EDL and soleus
at least 1130 and 1573 myoﬁbers, respectively, were analyzed from three animals per genotype/treatment.
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KDHOM mice compared to WT mice (Table 3). Despite these diﬀerences,
the oxygen consumed is the same between genotypes while resting and
under MIT (Table 3). This ﬁnding is more surprising given that VAChTKDHOM mice weigh signiﬁcantly less than WT mice (Table 3).
Given that skeletal muscles may be similarly aﬀected in individuals
with VAChT mutations, we tested if increasing the levels of ACh at the
synaptic cleft reverses the functional and morphological features found
in VAChT-KDHOM mice. To address this, WT and VAChT-KDHOM mice
were treated with the cholinesterase inhibitor pyridostigmine (1 mg/kg,
twice daily) for 28 days. We then compared the muscle ﬁber average
CSA among the diﬀerent treatments and genotypes in the EDL and soleus muscles. In this case, we speciﬁcally compared the distribution of
muscles sizes using a cumulative frequency graph (Fig. 5C and D) due to
the inherent high variability of muscle sizes across genotypes and following pyridostigmine treatments. This analysis revealed that pyridostigmine partially restores the size of muscle ﬁbers in the EDL of
VAChT-KDHOM mice (Table 4 and Fig. 5A and C). Although the treatment reduces the CSA of WT-treated compared with non-treated WT
mice (Table 4 and Fig. 5C), the size of muscle ﬁbers in non-treated
VAChT-KDHOM mice remains reduced compared to treated WT mice
(Fig. 5A and C). In the soleus muscle, pyridostigmine partially reduces
the hypertrophy observed in VAChT-KDHOM muscle ﬁbers (Fig. 5B and
D). These ﬁndings led us to ask if pyridostigmine treatment improves
motor function in VAChT-KDHOM mice. We found that animals treated
with pyridostigmine perform better in the open-ﬁeld task (Table 4).
VAChT-KDHOM mice treated with pyridostigmine did not perform better
in the rotarod or wire-hanging test based on a Kruskal-Wallis with
Dunn's multiple comparison test. However, intra-genotype comparisons
revealed that VAChT-KDHOM mice treated with pyridostigmine perform
2.5 times better on both tests compared with vehicle treated VAChTKDHOM mice (Table 4). These diﬀerences were signiﬁcant using a twotailed unpaired student t-test.

2018). For example, we previously showed that NMJs in the diaphragm
from VAChT-KDHOM mice exhibit several abnormalities, including altered recycling of synaptic vesicles (Rodrigues et al., 2013). Those
published ﬁndings led us to hypothesize that reduced cholinergic
transmission may diﬀerentially aﬀect the size and biochemical properties of muscle ﬁber subtypes. Thus, in the present study, we investigated the impact of lowering ACh on the fast-contracting EDL, the
slow-contracting soleus, and the gastrocnemius muscles.

4.1. Fast type muscle ﬁbers are preferentially aﬀected by reduced
cholinergic transmission
Diﬀerent mouse models of neuromuscular disorders have revealed
that fast-twitch skeletal muscles are more susceptible to atrophy than
slow-contracting muscles (Harandi et al., 2014; Wang and Pessin, 2013;
Biral et al., 1989). In addition, denervation or tetrodotoxin (TTX)
blockade of nerve impulses preferentially cause the atrophy of fast type
muscle ﬁbers in the diaphragm (Aravamudan et al., 2006) and gastrocnemius muscles (Zhan and Sieck, 1992). We found that fast-twitch
muscle ﬁber types (2B, 2X) are smaller in the EDL muscle of VAChTKDHOM compared with WT mice using light microscopy. Ultrastructural
analysis corroborated this ﬁnding, and revealed that myoﬁbrils degrade
in muscle ﬁbers of the EDL muscle from VAChT-KDHOM mice. Interestingly, the EDL muscle of VAChT-KDHOM mice contained fewer type
2B and more type 2X ﬁbers compared to WT mice. This shift in the ratio
of muscle ﬁber types in fast muscles has also been observed in aged
animals (Larsson and Ansved, 1995; Larsson et al. 1993, 1995), where
cholinergic transmission has been found to also be altered.
In addition to cellular changes, reduced cholinergic transmission
also aﬀects the molecular composition of the EDL muscle. We found
that Atrogin-1 is reduced while no changes were found in MuRF1 in the
EDL muscle of VAChT-KDHOM mice. This ﬁnding was surprising because
muscle ﬁbers atrophy in the EDL muscle of adult VAChT-KDHOM mice,
and Atrogin-1 and MuRF1 promote muscle atrophy when induced
(Bodine and Baehr, 2014). However, the pro-myogenic genes MyoD and
myogenin are reduced in the EDL of VAChT-KDHOM mice. In addition to
playing critical roles in muscle biogenesis, myogenin and MyoD also
regulate the expression of Atrogin-1 and MuRF1 (Bonaldo and Sandri,
2013; Hyatt et al., 2003; Moresi et al., 2010). The observed reduction in
myogenin, MyoD, and Atrogin-1 expression in the EDL muscle from
VAChT-KDHOM suggests that reduced cholinergic transmission inhibits
myogenesis but also atrophy in adult fast type muscles. These ﬁndings
thus raise the possibility that myogenesis is impaired during developmental stages and/or the growth of newly formed muscle ﬁbers is inhibited in the EDL of adult VAChT-KDHOM mice, potentially accounting
for fewer and smaller muscle ﬁbers. This is a possibility that can be
assessed in future studies designed to analyze the number and size of
muscle ﬁbers during development in addition to myogenin and Myod
expression in VAChT-KDHOM mice. If the formation and growth of

4. Discussion
Most CMS cases are related to mutations in postsynaptic proteins
and the prevalence of pre-synaptic mutations are very rare and, until
now, only found in SNAP25B (Shen et al., 2014), Synaptotagin-2
(Herrmann et al., 2014), Synaptobrevin-1 (Shen et al., 2017), MUNC13-1
(Engel et al., 2016), ChAT (Byring et al., 2002; Ohno et al., 2001), and
CHT- 1 (Bauché et al., 2016). However, recent reports revealed congenital myasthenia in individuals caused by mutations in the VAChT
gene (Aran et al., 2017; Schwartz et al., 2018; O'Grady et al., 2016).
Using VAChT mouse models to study CMS (VAChT-KDHOM and VAChTKnockout), our group has found motor (Prado et al., 2006), cardiac
(Lara et al., 2010), and synaptic (de Castro et al., 2009; Lima et al.,
2010; Prado et al., 2006; Rodrigues et al., 2013) alterations that resemble some of the features later discovered in patients with VAChT
mutations (O'Grady et al., 2016; Aran et al., 2017; Schwartz et al.,

Table 4
Results of the treatment with Pyridostigmine (PYR) on mice muscle histology and behavior.
HISTOLOGY

WT

WTPYR

EDL – CSA (μm )
Soleus – CSA (μm2)

1191 ± 28.9
1199 ± 364

998.7 ± 24.8
1031 ± 59.1

BEHAVIOR

WT

WTPYR

2

Open-ﬁeld
Rotarod (s)
Wire-hang (s)

95 ± 27
225 ± 100
28.4 ± 10

VAChT-KDHOM
a

a

1009 ± 28.4
1258 ± 97.7

VAChT KDHOM

VAChT KDHOM

46 ± 11
104 ± 60.3b
5.0 ± 1.1ab

83.4 ± 16.7
263 ± 29
12 ± 2.1

PYR

a

936.5 ± 23
1535 ± 168.7

ab

106.4 ± 18
271 ± 64
39.2 ± 6.2

VAChT-KDHOM

c

Statistics
p = 0.0007#
NS#

PYR

Statistics
p = 0.0007#
p = 0.03
p = 0.0007

Statistical analysis was deployed to compare diﬀerences between at least 3 WT and 3 VAChT-KDHOM mice. Values represent Mean ± SEM. Statistics for rotarod and
wire-hang: Kruskal-Wallis with Dunn's multiple comparison test. For the EDL, at least 1130 myoﬁbers in a n = 3 animals per genotype/treatment were analyzed. In
soleus, at least 1573 myoﬁbers in a n = 3 animals per genotype/treatment were analyzed. For behavior n = 5 animals per genotype/treatment. a Statistically
diﬀerent from WT; b diﬀerent from WTPYR; c diﬀerent from VAChT-KDHOM. #One-way ANOVA followed by Newman-Keuls Multiple Comparison Test.
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muscle ﬁbers is disrupted in the EDL muscle of VAChT-KDHOM, it would
resemble ﬁndings reported following analysis of the R6/2 mice model
for Huntington's disease where muscle ﬁber maturation is also impaired
and partly due to progressive Cl-channel defects (Miranda et al., 2017).
Irrespective, our ﬁndings show that reducing cholinergic transmission
by 65% is deleterious to fast type muscle ﬁbers.

following each nerve impulse in a mouse nerve muscle preparation
(Vizi and Somogyi, 1989). This eﬀect is mediated by nicotinic autoreceptors with positive feedback in the NMJ (Bowman et al., 1990;
Starke et al., 1989). In addition, several experiments have shown a
modulatory eﬀect of presynaptic ACh release by agonists and antagonists of presynaptic muscarinic receptors (Ganguly and Das, 1979;
Wessler, 1989; Santafé et al., 2003). Future experiments will be needed
to clarify this point. Importantly, the successful reversion of some of the
muscle changes and performance improvement obtained with pyridostigmine treatment of VAChT-KDHOM mice have interesting implications for neuromuscular disorders, such as CMS. Indeed, a mild
clinical improvement was observed in patients with a biallelic variant
of the VAChT gene that were treated with pyridostigmine (O'Grady
et al., 2016). Taken together, these data emphasize the importance of
maintaining normal cholinergic activity for preserving the structure of
skeletal muscle ﬁbers, and ultimately motor function.

4.2. Type 1 muscle ﬁbers size increase under reduced cholinergic
transmission
In contrast to the EDL, reduced cholinergic transmission causes
muscle ﬁbers in the soleus to hypertrophy. This ﬁnding was unexpected
because the soleus is a tonic muscle, and we thus expected that reducing
ACh by 65% would be detrimental to the viability of the soleus muscle.
What could then account for the increased size of muscle ﬁbers in the
soleus muscle? One possibility is that atrophy of the gastrocnemius
increases the functional load on the soleus to maintain balance thereby
leading to compensatory hypertrophy of muscle ﬁbers in the soleus.
This possibility is supported by published studies showing that compensatory hypertrophy occurs in the soleus muscle (Allen et al., 2001)
(Hanzlíková et al., 1975; Minderis et al., 2016). Another possibility, not
mutually exclusive, is that type 1 ﬁbers, which make a large proportion
of the soleus muscle, resist degeneration and instead hypertrophy when
cholinergic transmission is reduced. In this regard, Pax-7 and MyoD are
both increased in the soleus muscle of VAChT-KDHOM mice, both genes
important for myogenesis. Thus, mechanical overload could promote
the proliferation of Pax-7-expressing satellite cells, thereby leading to
increased expression of myogenic factors. However, the increased oxidative proﬁle of the soleus muscle in VAChT-KDHOM mice suggests an
alternative possibility. In these mice, the soleus is populated by more
type 1 muscle ﬁbers and has augmented expression of PGC1-α, and
MTND-1. Accompanying these changes was a loss of type 2A muscle
ﬁbers, further indicating that muscle ﬁbers with a fast type proﬁle are
more aﬀected by reduced cholinergic transmission preferentially. These
changes are also found in aged skeletal muscles, where there is a shift
from fast to slow ﬁber types (Holloszy et al., 1991; Larsson and Ansved,
1995; Miljkovic et al., 2015; Thompson, 1994). Therefore, it may be
possible that the changes observed in the soleus muscle of VAChTKDHOM mice are more indicative of a premature aged phenotype.
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